Hidradenitis suppurativa markedly decreases quality of life and professional activity
Top Cited Papers
- 30 April 2010
- journal article
- other
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 62 (4), 706-708.e1
- https://doi.org/10.1016/j.jaad.2009.09.021
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativaBritish Journal of Dermatology, 2007
- Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasisBritish Journal of Dermatology, 2007
- Atopic Dermatitis: Impact on the Quality of Life of Patients and Their PartnersDermatology, 2007
- Quality of life impairment in hidradenitis suppurativa: A study of 61 casesJournal of the American Academy of Dermatology, 2007
- Infliximab for severe hidradenitis suppurativa: Transient clinical efficacy in 7 consecutive patientsJournal of the American Academy of Dermatology, 2007
- Effects of skin care and makeup under instructions from dermatologists on the quality of life of female patients with acne vulgarisThe Journal of Dermatology, 2006
- Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis TrialAnnals Of The Rheumatic Diseases, 2006
- Etanercept: effective in the management of hidradenitis suppurativaBritish Journal of Dermatology, 2006
- Life quality assessment among patients with atopic eczemaBritish Journal of Dermatology, 2005
- Handicap in Darier's disease and Hailey-Hailey diseaseBritish Journal of Dermatology, 1996